Skip to content
2000
Volume 3, Issue 5
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Lamotrigine (LTG) is a modern, effective and well-tolerated antiepileptic drug (AED) with an expected low teratogenic potential and therefore regarded as a relative safe drug for women of reproductive age. Recent studies, however, have demonstrated that co-administration of LTG and combined oral contraceptives (OC's) and pregnancy interfere with the metabolism of LTG with the risk of therapeutic failure. It is therefore recommended that plasma level of LTG should be closely monitored before and after introduction or discontinuation of OC's and monthly during pregnancy.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/157018006777574267
2006-07-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/157018006777574267
Loading

  • Article Type:
    Research Article
Keyword(s): anticonception; interaction; Lamotrigine; pharmacokinetics; pregnancy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test